Patents by Inventor Gregg Strohmeier

Gregg Strohmeier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140336114
    Abstract: The present invention provides formulations of cysteine knot proteins, including TGF-? superfamily proteins and bone morphogenic proteins that are pH stabilized. In particular, the present invention relates to the observation that certain buffers enhance the stability of cysteine knot proteins, including TGF-? superfamily proteins and bone morphogenic proteins. In particular, disclosed herein are liquid and lyophilized formulations prepared with a glycylglycine and tartaric acid buffers to stabilize the pH of the formulation.
    Type: Application
    Filed: November 25, 2013
    Publication date: November 13, 2014
    Applicant: STRYKER CORPORATION
    Inventors: David D. Hile, Gregg Strohmeier
  • Patent number: 8796201
    Abstract: Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Grant
    Filed: November 4, 2011
    Date of Patent: August 5, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lu Shan, Michael Bethune, Chaitan Khosla, Jonathan Gass, Gail G. Pyle, Gary M. Gray, Indu Isaacs, Gregg Strohmeier
  • Publication number: 20130172254
    Abstract: The present invention provides formulations of cysteine knot proteins, including TGF-? superfamily proteins and bone morphogenic proteins that are pH stabilized. In particular, the present invention relates to the observation that certain buffers enhance the stability of cysteine knot proteins, including TGF-? superfamily proteins and bone morphogenic proteins. In particular, disclosed herein are liquid and lyophilized formulations prepared with a glycylglycine and tartaric acid buffers to stabilize the pH of the formulation.
    Type: Application
    Filed: September 14, 2012
    Publication date: July 4, 2013
    Applicant: STRYKER CORPORATION
    Inventors: David Hile, Gregg Strohmeier
  • Publication number: 20120156253
    Abstract: Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Application
    Filed: November 4, 2011
    Publication date: June 21, 2012
    Inventors: Lu Shan, Michael Bethune, Chaitan Khosla, Jonathan Gass, Gail G. Pyle, Gary M. Gray, Indu Isaacs, Gregg Strohmeier
  • Publication number: 20110224410
    Abstract: The present invention provides formulations of cysteine knot proteins, including TGF-? superfamily proteins and bone morphogenic proteins that are pH stabilized. In particular, the present invention relates to the observation that certain buffers enhance the stability of cysteine knot proteins, including TGF-? superfamily proteins and bone morphogenic proteins. In particular, disclosed herein are liquid and lyophilized formulations prepared with a glycylglycine and tartaric acid buffers to stabilize the pH of the formulation.
    Type: Application
    Filed: September 17, 2010
    Publication date: September 15, 2011
    Inventors: David HILE, Gregg STROHMEIER
  • Publication number: 20080095710
    Abstract: Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Application
    Filed: July 10, 2007
    Publication date: April 24, 2008
    Inventors: Lu Shan, Michael Bethune, Chaitan Khosla, Jonathan Gass, Gail Pyle, Gary Gray, Indu Isaacs, Gregg Strohmeier
  • Publication number: 20050249719
    Abstract: Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Application
    Filed: October 19, 2004
    Publication date: November 10, 2005
    Inventors: Lu Shan, Michael Bethune, Chaitan Khosla, Jonathan Gass, Gail Pyle, Gary Gray, Indu Isaacs, Gregg Strohmeier